Microbiotix, Inc. - Product Pipeline Review - 2016

  • ID: 3691111
  • Company Profile
  • 52 pages
  • Global Markets Direct
1 of 4
Microbiotix, Inc. - Product Pipeline Review - 2016

Summary

‘Microbiotix, Inc. - Product Pipeline Review - 2016’, provides an overview of the Microbiotix, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Microbiotix, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Microbiotix, Inc.
- The report provides overview of Microbiotix, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Microbiotix, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Microbiotix, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Microbiotix, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Microbiotix, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Microbiotix, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Microbiotix, Inc. Snapshot

Microbiotix, Inc. Overview

Key Information

Key Facts

Microbiotix, Inc. - Research and Development Overview

Key Therapeutic Areas

Microbiotix, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Microbiotix, Inc. - Pipeline Products Glance

Microbiotix, Inc. - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

Microbiotix, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Microbiotix, Inc. - Drug Profiles

filociclovir

Product Description

Mechanism of Action

R&D Progress

MBX-700

Product Description

Mechanism of Action

R&D Progress

MBX-500

Product Description

Mechanism of Action

R&D Progress

MBX-701

Product Description

Mechanism of Action

R&D Progress

MBX-900

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit 16S rRNA for Tuberculosis

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit T3SS for Pseudomonas Aeruginosa Infections

Product Description

Mechanism of Action

R&D Progress

KKL-35

Product Description

Mechanism of Action

R&D Progress

MBX-2168

Product Description

Mechanism of Action

R&D Progress

MBX-2319

Product Description

Mechanism of Action

R&D Progress

MBX-2329

Product Description

Mechanism of Action

R&D Progress

MBX-2359

Product Description

Mechanism of Action

R&D Progress

MBX-2402

Product Description

Mechanism of Action

R&D Progress

MBX-2546

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit DNA Helicase for Infectious Diseases

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Ebola Virus Infection

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Fungal Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Gram-Negative Bacterial Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit Anthrax Lethal Factor Toxin for Anthrax

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit bNOS for MRSA Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit BoNT/A LC for Botulism

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit DNA Synthesis for Gram-Negative and Gram-Positive Bacterial Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit NPC1 for Filovirus Infections

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit PSAC for Malaria

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit the Fatty Acid Synthesis II for Pseudomonas Aeruginosa Infections

Product Description

Mechanism of Action

R&D Progress

Microbiotix, Inc. - Pipeline Analysis

Microbiotix, Inc. - Pipeline Products by Target

Microbiotix, Inc. - Pipeline Products by Route of Administration

Microbiotix, Inc. - Pipeline Products by Molecule Type

Microbiotix, Inc. - Pipeline Products by Mechanism of Action

Microbiotix, Inc. - Dormant Projects

Microbiotix, Inc. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Microbiotix, Inc., Key Information

Microbiotix, Inc., Key Facts

Microbiotix, Inc. - Pipeline by Indication, 2016

Microbiotix, Inc. - Pipeline by Stage of Development, 2016

Microbiotix, Inc. - Monotherapy Products in Pipeline, 2016

Microbiotix, Inc. - Phase I, 2016

Microbiotix, Inc. - Preclinical, 2016

Microbiotix, Inc. - Discovery, 2016

Microbiotix, Inc. - Pipeline by Target, 2016

Microbiotix, Inc. - Pipeline by Route of Administration, 2016

Microbiotix, Inc. - Pipeline by Molecule Type, 2016

Microbiotix, Inc. - Pipeline Products by Mechanism of Action, 2016

Microbiotix, Inc. - Dormant Developmental Projects,2016

List of Figures

Microbiotix, Inc. - Pipeline by Top 10 Indication, 2016

Microbiotix, Inc. - Pipeline by Stage of Development, 2016

Microbiotix, Inc. - Monotherapy Products in Pipeline, 2016

Microbiotix, Inc. - Pipeline by Top 10 Target, 2016

Microbiotix, Inc. - Pipeline by Route of Administration, 2016

Microbiotix, Inc. - Pipeline by Molecule Type, 2016

Microbiotix, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll